ClinicalTrials.gov
public full text
Public Domain
Multiple Ascending Dose Study in Healthy Subjects
This will be a Phase 1, randomized, double-blind, single center, placebo-controlled, multiple ascending dose (MAD) study in a maximum of 3 cohorts of 8 healthy male and female subjects each. Subjects in Cohorts 1, 2 and 3 will receive ascending multiple IV doses of NPT189 or matching placebo.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of MORF 057 to Evaluate Single and Multi Ascending Doses in Healthy Volunteers#864066
- Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics#825521
- A Phase I SAD and MAD Clinical Trial of CNM-Au8 in Healthy Male and Female Volunteers#886541
- Single and Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects#908157
- Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies#875105
Record · ID 1033333
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive